MEXICO
CITY, July 2, 2024 /PRNewswire/ -- Genomma
Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma
Lab" or "the Company") today announced that it will report its
Second Quarter 2024 Earnings Results on Wednesday, July 24,
2024, after the Mexican Stock Exchange (BMV) close. The
company also announced that it will hold a conference call on
Thursday, July 25, 2024, at
1 p.m. ET to discuss its quarterly
financial results.
Presenters: Mr. Marco
Sparvieri, Chief Executive Officer
Mr. Antonio Zamora, Chief Financial
Officer
Christianne Ibanez, Investor
Relations Officer
Date: Thursday, July 25,
2024
Time: 1:00 p.m. (ET) /
11:00 a.m. (Mexico City Time)
Webcast: To register please access via direct
link
(You will receive an email confirmation with an
invitation)
About Genomma Lab Internacional
Genomma Lab
Internacional, S.A.B. de C.V. is one of the leading pharmaceutical
and personal care products companies in Mexico with an increasing international
presence. Genomma Lab develops, sells and markets a broad range of
premium branded products, many of which are leaders in the
categories in which they compete in terms of sales and market
share. Genomma Lab relies on the combination of a successful new
product development process, a consumer-oriented marketing, a broad
retail distribution network and a low-cost, highly flexible
operating model.
Genomma Lab's shares are listed on the Mexican Stock Exchange
under the ticker "LAB B" (Bloomberg: LABB:MM).
Note on Forward-Looking Statements
This report may
contain certain forward-looking statements and information relating
to the Company that reflect the current views and/or expectations
of the Company and its management with respect to its performance,
business and future events. Forward looking statements include,
without limitation, any statement that may predict, forecast,
indicate or imply future results, performance or achievements, and
may contain words like "believe," "anticipate," "expect,"
"envisages," "will likely result," or any other words or phrases of
similar meaning. Such statements are subject to a number of risks,
uncertainties and assumptions. We caution you that a number of
important factors could cause actual results to differ materially
from the plans, objectives, expectations, estimates and intentions
expressed in this presentation and in oral statements made by
authorized officers of the Company. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of their dates. The Company undertakes no obligation
to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
View original
content:https://www.prnewswire.com/news-releases/genomma-lab-internacional-sab-de-cv-second-quarter-2024-earnings-results-conference-call-302188414.html
SOURCE Genomma Lab Internacional, S.A.B. de C.V.